Concepedia

Author

Guido Furlotti

Angelini Pharma (Italy)ORCID

Also Known As

G. Furlotti, Guido Furlotti

13

Publications

274

Citations

9

H-Index

23

Concepts

All Affiliations

Angelini Pharma (Italy)Sapienza University of RomeItalian Institute of TechnologyUniversity of Bari Aldo Moro
GF

About

Guido Furlotti is an author at Angelini Pharma (Italy) specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

157

2

Biochemistry

3

3

105

3

Natural Sciences

2

2

81

4

Engineering

1

1

18

5

Chemical Biology

1

1

41

Guido Furlotti

×

9

Publications

265

Citations

9

H-Index

YearCitations

New anti-viral drugs for the treatment of the common cold

Caterina Maugeri, Maria Alessandra Alisi, Claudia Apicella,

Bioorganic & Medicinal Chemistry

2008

52

Hit Optimization of 5-Substituted-<i>N</i>-(piperidin-4-ylmethyl)-1<i>H</i>-indazole-3-carboxamides: Potent Glycogen Synthase Kinase-3 (GSK-3) Inhibitors with in Vivo Activity in Model of Mood Disorders

Guido Furlotti, Maria Alessandra Alisi, Nicola Cazzolla,

Journal of Medicinal Chemistry

2015

41

Discovery and Pharmacological Profile of New 1<i>H</i>-Indazole-3-carboxamide and 2<i>H</i>-Pyrrolo[3,4-<i>c</i>]quinoline Derivatives as Selective Serotonin 4 Receptor Ligands

Guido Furlotti, Maria Alessandra Alisi, Claudia Apicella,

Journal of Medicinal Chemistry

2012

40

Discovery of Novel Imidazopyridine GSK-3β Inhibitors Supported by Computational Approaches

Rosa Buonfiglio, Federica Prati, Martina Bischetti,

Molecules

2020

36

DPPH radical scavenging activity of paracetamol analogues

Maria Alessandra Alisi, Mario Brufani, Nicola Cazzolla,

Tetrahedron

2012

24

Optimization of Indazole-Based GSK-3 Inhibitors with Mitigated hERG Issue and <i>In Vivo</i> Activity in a Mood Disorder Model

Federica Prati, Rosa Buonfiglio, Guido Furlotti,

ACS Medicinal Chemistry Letters

2020

21

Virtual Screening Approach and Investigation of Structure–Activity Relationships To Discover Novel Bacterial Topoisomerase Inhibitors Targeting Gram-Positive and Gram-Negative Pathogens

Gabriele Magarò, Federica Prati, Barbara Garofalo,

Journal of Medicinal Chemistry

2019

18

Deep eutectic solvents meet safe, scalable and sustainable hydrogenations enabled by aluminum powder and Pd/C

Francesco Messa, Giuseppe Dilauro, Andrea Nicola Paparella,

Green Chemistry

2022

18

Targeting Serotonin 2A and Adrenergic α<sub>1</sub> Receptors for Ocular Antihypertensive Agents: Discovery of 3,4‐Dihydropyrazino[1,2‐<i>b</i>]indazol‐1(2<i>H</i>)‐one Derivatives

Guido Furlotti, Maria Alessandra Alisi, Nicola Cazzolla,

ChemMedChem

2018

15

Page 1